Viking Therapeutics (VKTX) announced the appointment of Neil Aubuchon as chief commercial officer. Aubuchon brings more than two decades of biopharmaceutical industry experience spanning leadership roles across global commercial and marketing functions including focus within the cardiometabolic space. Prior to joining Viking, Aubuchon was the chief commercial officer at AbCellera (ABCL).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
- Viking Therapeutics: External Validation and Same-Molecule Strategy De-Risk Obesity Program, Supporting Buy Rating
- H.C. Wainwright says Lilly’s topline results de-risk Viking oral VK2735 program
- Crypto Currents: Bitcoin settlement volume flips Visa
- Viking Therapeutics call volume above normal and directionally bullish